1,757 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Uptrend
Article Searches
EU Grants Brexit Extension, But Not For Long (Wall Street Breakfast Podcast) https://seekingalpha.com/article/4250467-eu-grants-brexit-extension-long-wall-street-breakfast-podcast?source=feed_all_articles Mar 22, 2019 - Today's Top Stories: E.U. grants a Brexit extension, but not for long; Goldman Sachs cuts May's deal chances to 50%; and Indonesia cancels Boeing jet order. If you are interested in listening to Wall
Wall Street Breakfast: EU Grants A Brexit Extension, But Not For Long https://seekingalpha.com/article/4250458-wall-street-breakfast-eu-grants-brexit-extension-long?source=feed_tag_wall_st_breakfast Mar 22, 2019 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). The European Union decided to give the Unit
Bristol-Myers' Celgene Buyout Still Uncertain Amid Opposition http://www.zacks.com/stock/news/362782/bristol-myers-celgene-buyout-still-uncertain-amid-opposition?cid=CS-ZC-FT-362782 Mar 21, 2019 - The acquisition deal between Bristol-Myers and Celgene faces opposition from stakeholders of Bristol-Myers. The future of the deal depends on the outcome of the Special Meeting in April.
Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $15. ... http://www.gurufocus.com/news/835656/merck--co-inc-mrk-chairman-president--ceo-kenneth-c-frazier-sold-158-million-of-shares Mar 20, 2019 - Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $15.8 million of Shares, Stocks: MRK, release date:Mar 20, 2019
Glaxo Presents Encouraging Data on Endometrial Cancer Drug http://www.zacks.com/stock/news/362265/glaxo-presents-encouraging-data-on-endometrial-cancer-drug?cid=CS-ZC-FT-362265 Mar 20, 2019 - Glaxo (GSK) presents encouraging data from phase I/II study on endometrial cancer drug, dostarlimab.
Winning Bounce/Lag Momentum Stocks For Week 12 Of 2019 (3/18-3/22) https://seekingalpha.com/article/4249890-winning-bounce-lag-momentum-stocks-week-12-2019-3-18minus-3-22?source=feed_all_articles Mar 19, 2019 - Cumulative Bounce/Lag gains are now at 42.73% so far in 2019.Last week the S&P 500 Index gained 2.89%, while the five B/L Momentum picks gained an average of 4.98% when tight stop-loss orders were app
IPO Update: Precision BioSciences Readies Plan For IPO https://seekingalpha.com/article/4249820-ipo-update-precision-biosciences-readies-plan-ipo?source=feed_tag_ipo_analysis Mar 19, 2019 - Precision BioSciences intends to raise $126.4 million in an IPO of its common stock.The firm is developing a gene editing platform for disease treatments, research, and crop modification applications.
Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer http://www.zacks.com/stock/news/361461/roches-tecentriq-gets-fda-approval-for-difficult-lung-cancer?cid=CS-ZC-FT-361461 Mar 19, 2019 - Roche (RHHBY) gets an FDA approval of sBLA for Tecentriq in combination with chemotherapy for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).
Top Research Reports for Merck, Adobe & Broadcom http://www.zacks.com/research-daily/360711/top-research-reports-for-merck-adobe-broadcom?cid=CS-ZC-FT-360711 Mar 18, 2019 - Top Research Reports for Merck, Adobe & Broadcom
AstraZeneca Up This Year on New Drugs & Pipeline Progress http://www.zacks.com/stock/news/359997/astrazeneca-up-this-year-on-new-drugs-pipeline-progress?cid=CS-ZC-FT-359997 Mar 18, 2019 - AstraZeneca's (AZN) stock is on an upward trajectory this year. Let us have a look at the reasons for the same.

Pages: 123456...176

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Merck & Company
MRK - Google Finance https://www.google.com/finance?q=MRK Industry related info and international coverage Summary News
MRK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=MRK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options